On the other hand, p300 can promote the malignant progression of prostate cancer by increasing the levels of H3K18ac, H3K27ac and H4ac in the transcription start site (TSS) and antioxidant response element (ARE) regions, which in turn affects the transcriptional level [63]. This evidence concerns the gene EP300 and prostate cancer.